Q&A: Where are we in the COVID-19 vaccine race?

Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. U.S. drugmaker Pfizer Inc and German partner BioNTech SE are the first to announce data from a late-stage clinical trial. The next data releases will likely be from U.S. biotech firm Moderna Inc, possibly in November, and from Britain-based AstraZeneca Plc with the University of Oxford in November or December.

Leave a Reply